Skip to content

Misoprostol for Second Trimester Termination of Pregnancy

A Comparison Between Vaginal Misoprostol vs. Buccal Misoprostol For Second Trimester Termination of Pregnancy

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02048098
Enrollment
130
Registered
2014-01-29
Start date
2014-01-31
Completion date
2014-12-31
Last updated
2015-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abortion, Induced

Keywords

misoprostol, Labor, Induced, Pregnancy Trimester, Second, Abortion, Induced

Brief summary

The purpose of this study is to compare the efficacy of 400 µg vaginal misoprostol per 3 hours to 400 µg buccal misoprostol per 3 hours in second trimester termination of viable pregnancy

Interventions

DRUGVaginal misoprostol

400 µg vaginal misoprostol per 3 hours up to 6 doses. The treatment will be withold if the patient has strong uterine contractions. If abortion had not occured in 24 hour after the start of the study a second course of 400 µg vaginal misoprostol per 3 hours up to 6 doses will be administered. If abortion had not occured in 48 hour after the start of the study it will be considered treatment failure and patient will be offered another induction/delivery method or to continue protocol.

400 µg buccal misoprostol per 3 hours up to 6 doses. The treatment will be withold if the patient has strong uterine contractions. If abortion had not occured in 24 hour after the start of the study a second course of 400 µg buccal misoprostol per 3 hours up to 6 doses will be administered. If abortion had not occured in 48 hour after the start of the study it will be considered treatment failure and patient will be offered another induction/delivery method or to continue protocol.

Sponsors

Ataturk University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
16 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* gestational age between 12-24 weeks * live fetus * singleton pregnancy * Bishop score \<5 * no uterine contraction

Exclusion criteria

* prostaglandin allergy * a scar in uterus * uterine abnormality * premature rupture of membranes

Design outcomes

Primary

MeasureTime frameDescription
Induction to fetal expulsion interval15 minutes after fetus deliveredTime elapsed between administration of the first misoprostol dose until expulsion of the fetus

Secondary

MeasureTime frameDescription
Delivery within 48 hours48 hours
Use of additional interventionsOne weekthe patients who did not delivered within 48 hours will considered as failed induction and will be offered another method of induction/delivery or to continue same protocol.
Expected pain before induction and perceived (actual) pain after abortion completedwithin 1 hour after randomisation and after 12 hour after complete abortion/placenta removedExpected and perceived pain will be measured by VAS
Rate of complete abortion12 hour after fetus and placenta removed
Delivery within 24 hours24 hour

Other

MeasureTime frameDescription
maternal complicationsone weeksincludes, but not limited blood, transfusions, laparatomy, nausea, vomiting, fever, genital tract injury
difference in hematocrit measured at entry of the study and after delivery/abortionat recruitment and 24 hour after abortion
total misoprostol dose48 hours

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 15, 2026